Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute ...

IDWeek 2024 was held at the Los Angeles Convention Center in Downtown Los Angeles, CA, USA, from 16–19 October. Phoebe Hall ...

We are writing to urgently highlight the unprecedented flooding that has devastated eastern Spain, particularly in the Valencia region, beginning on Oct 29, 2024. As of Nov 25, this catastrophic event ...

Christy Fischer has never felt lost or sorry for herself during the 18 years since her diagnosis with stage IV lung cancer.

On Oct 29, WHO published its annual Global Tuberculosis Report, with tuberculosis resuming its position as the top infectious ...

In the early 1990s, a pivotal randomised trial sponsored by the National Institute of Neurological Disorders and Stroke ...

The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...

The COVID-19 pandemic reminded us of what vaccines can do to prevent life-threatening diseases.1 Respiratory infections such ...

Building on the evidence from the first paper in this Series highlighting the fundamental importance of healthy and nurturing ...

Globally, the prevalence of adolescents experiencing symptoms of anxiety and depression has been rising steeply in the past two decades,1 and diagnoses continue to increase.2 Symptoms of anxiety and ...

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...

The centrality of the first 1000 days—from conception to 2 years of age—for early childhood development is recognised in ...